9G2 — Singapore Institute of Advanced Medicine Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- SG$37.17m
- SG$86.67m
- SG$16.65m
Annual cashflow statement for Singapore Institute of Advanced Medicine Holdings, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -9.35 | -12.4 | -18.1 | -37.4 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 1.38 | -1.11 | 3.96 | 16.3 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.411 | 2.47 | 5.11 | -4.3 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Cash from Operating Activities | -2.43 | -5.81 | -3.24 | -12.9 |
| Capital Expenditures | -5.47 | -4.11 | -14.4 | -0.534 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 0.222 | 7.83 | 13 | 0.278 |
| Sale of Fixed Assets | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -5.25 | 3.72 | -1.45 | -0.256 |
| Financing Cash Flow Items | -3.51 | -2.7 | -3.74 | -2.2 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 8.83 | 7.84 | -0.099 | 5.3 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 1.16 | 5.75 | -4.79 | -7.89 |